<DOC>
	<DOCNO>NCT00004359</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate immunomodulation extracorporeal photochemotherapy ( ECP ) patient epidermolysis bullosa acquisita . II . Investigate effect ECP lymphocyte activity .</brief_summary>
	<brief_title>Phase II Pilot Study Extracorporeal Phototherapy Epidermolysis Bullosa Acquisita</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Oral methoxsalen ( 8-MOP ) administer 90 minute prior leukapheresis . Blood mononuclear cell expose ultraviolet A light 3 hour , return patient . The process repeat 2 successive day . Patients re-treated every 3 4 week total 6 treatment skin clear .</detailed_description>
	<mesh_term>Epidermolysis Bullosa</mesh_term>
	<mesh_term>Epidermolysis Bullosa Acquisita</mesh_term>
	<mesh_term>Methoxsalen</mesh_term>
	<criteria>Active epidermolysis bullosa acquisita</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2000</verification_date>
	<keyword>dermatologic disorder</keyword>
	<keyword>epidermolysis bullosa</keyword>
	<keyword>genetic disease dysmorphic syndrome</keyword>
	<keyword>rare disease</keyword>
</DOC>